Coronavirus disease 2019 (COVID-19) is the most serious public health problem in China. Children with diabetes are also among the population susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Traffic problems caused by epidemic prevention and control increase the difficulty in the management of children with severe diabetes. In order to control the spread of epidemic, children with mild diabetes are advised to be managed at home and in the community. However, how to treat children with severe diabetes effectively and safely during the outbreak of COVID-19 brings great challenges to primary doctors. The Subspecialty Group of Endocrinology and Metabolism, Society of Pediatrics, Chinese Medical Association and the Subspecialty Group of Endocrinology and Metabolism, Society of Pediatrics, Chinese Medical Doctor Association have developed the recommendations on the identification and transfer of children with critical diabetes during the COVID-19 outbreak, which provide a reference for primary doctors to quickly assess the severity of patient's condition and treat the illness accordingly, thus reducing the risk of referral infection and improving clinical prognosis.
Key words
Coronavirus disease 2019 /
Diabetes /
Diabetic ketoacidosis /
Hypoglycemia /
Transfer /
Child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组. 新型冠状病毒肺炎流行病学特征分析[J]. 中华流行病学杂志, 2020, 41(2):145-151.
[2] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 2020, 395(10223):497-506.
[3] Wolfsdorf JI, Glaser N, Agus M, et al. ISPAD Clinical Practice Consensus Guidelines 2018:diabetic ketoacidosis and the hyperglycemic hyperosmolar state[J]. Pediatr Diabetes, 2018, 19(Suppl 27):155-177.
[4] Abraham MB, Jones TW, Naranjo D, et al. ISPAD Clinical Practice Consensus Guidelines 2018:assessment and management of hypoglycemia in children and adolescents with diabetes[J]. Pediatr Diabetes, 2018, 19(Suppl 27):178-192.
[5] 中华医学会儿科学分会内分泌遗传代谢学组, 《中华儿科杂志》编辑委员会. 儿童糖尿病酮症酸中毒诊疗指南(2009年版)[J]. 中华儿科杂志, 2009, 47(6):421-425.
[6] 中华医学会糖尿病学分会. 中国1型糖尿病诊治指南[M]. 北京:人民卫生出版社, 2012:1-282.
[7] 国家卫生健康委办公厅, 国家中医药管理局办公室. 新型冠状病毒肺炎诊疗方案(试行第六版)[EB/OL]. (2020-02-19)[2020-03-09]. http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml.
[8] Chen ZM, Fu JF, Shu Q, et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus[J]. World J Pediatr, 2020. DOI:10.1007/s12519-020-00345-5. Epub ahead of print.
[9] 曹冰燕, 巩纯秀, 吴迪, 等. 儿童糖尿病合并酮症酸中毒和高血糖高渗状态临床特征分析[J]. 临床儿科杂志, 2012, 30(12):1105-1109.
[10] 陆国平, 程晔. 儿科早期预警系统评分[J]. 中华实用儿科临床杂志, 2013, 28(18):1361-1364.
[11] Sambeeck SJV, Fuijkschot J, Kramer BW, et al. Pediatric early warning system scores:lessons to be learned[J]. J Pediatr Intensive Care, 2018, 7(1):27-32.
[12] 沈晓明, 王卫平. 儿科学[M]. 第7版. 北京:人民卫生出版社, 2008:30.
[13] 中华医学会儿科学分会急救学组, 中华医学会急诊医学分会儿科学组, 中国医师协会儿童重症医师分会. 儿童脓毒性休克(感染性休克)诊治专家共识(2015版)[J]. 中华儿科杂志, 2015, 53(8):576-580.
[14] 国家卫生健康委办公厅. 新型冠状病毒感染的肺炎病例转运工作方案(试行)[EB/OL]. (2020-01-28)[2020-03-09]. http://www.gov.cn/zhengce/zhengceku/2020-01/29/5472894/files/98dc13942a514dd0aced75e08680ad06.pdf.
PDF(1505 KB)
